EDAP TMS | EDAP - Gross Profit On Sales

Stock Price
3.83
Daily Change
-0.10 -2.42%
Monthly
-18.79%
Yearly
60.79%
Q1 Forecast
3.82

EDAP TMS reported EUR5.97M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
AngioDynamics USD 44.78M 2.93M Sep/2025
Boston Scientific USD 3.68B 136M Dec/2025
EDAP TMS EUR 5.97M 850K Sep/2025
Henry Schein USD 1.06B 37M Dec/2025
Medtronic USD 5.41B 27M Dec/2025
Veracyte USD 101.97M 10.69M Dec/2025